Back to Search
FERNADO CABANILLAS, MD
MD
Hematology & Oncology Physician
NPI: 1811052707IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
4069(PR)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE
Class of 1970
Research & Publications (20)
High incidence of non-neutropenic infections induced by rituximab plus fludarabine and associated with hypogammaglobulinemia: a frequently unrecognized and easily treatable complication.
PMID 16966368·Ann Oncol·2006
8-other
Diffuse large-cell lymphoma. Part I: clinical features, histology and prognosis.
PMID 19266733·P R Health Sci J·2009
6-review
Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma.
PMID 19150940·Ann Oncol·2009
8-other
Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma.
PMID 18973182·Cancer·2008
3-trial
The addition of rituximab to CHOP chemotherapy improves overall and failure-free survival for follicular grade 3 lymphoma.
PMID 18083690·Ann Oncol·2008
8-other
Variations in chemotherapy and radiation therapy in a large nationwide and community-based cohort of elderly patients with non-Hodgkin lymphoma.
PMID 17414466·Am J Clin Oncol·2007
4-observational
A phase I/II trial of pixantrone (BBR2778), methylprednisolone, cisplatin, and cytosine arabinoside (PSHAP) in relapsed/refractory aggressive non-Hodgkin's lymphoma.
PMID 17325899·Leuk Lymphoma·2007
3-trial
Non-Hodgkin's lymphoma. Clinical practice guidelines in oncology.
PMID 16507273·J Natl Compr Canc Netw·2006
6-review
Phase 2 study of fludarabine and paclitaxel in patients with recurrent low-grade non-Hodgkin's lymphoma.
PMID 17064994·Leuk Lymphoma·2006
3-trial
Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemia.
PMID 16331634·Cancer·2006
3-trial
Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia.
PMID 16502413·Cancer·2006
3-trial
Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis.
PMID 16879607·Eur J Haematol·2006
4-observational
Improvement of overall and failure-free survival in stage IV follicular lymphoma: 25 years of treatment experience at The University of Texas M.D. Anderson Cancer Center.
PMID 16575009·J Clin Oncol·2006
8-other
Immunosuppression and infectious complications in patients with stage IV indolent lymphoma treated with a fludarabine, mitoxantrone, and dexamethasone regimen.
PMID 15948158·Cancer·2005
8-other
High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine.
PMID 16145068·J Clin Oncol·2005
3-trial
A prospective randomized study to compare the molecular response rates between central lymphatic irradiation and intensive alternating triple chemotherapy in the treatment of stage I-III follicular lymphoma.
PMID 16111588·Int J Radiat Oncol Biol Phys·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 725 PONCE DE LEON, PARADA 37
SAN JUAN, PR 00918 - Phone
- (787) 771-7933
Quick Facts
- NPI
- 1811052707
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 56
- Publications
- 20
Are you this provider?
Claim Your Profile